Catalog Systems Vertical / domain-specific AI memory Abridge

Abridge

https://www.abridge.com/

Clinician-assist ambient documentation. Source mapping: every AI-generated summary element traced back to the source utterance. Audit-and-trust layer over episodic memory. Built on proprietary 1.5M+ medical-encounter dataset.

Active · Verified 2026-10-22 · fresh as of 2026-10-22 · 60 cited facts, 5 with a third-party source · Suggest a correction

At a glance

Type
Grounded-transcript provenance vendor fix
Tier
T1
Section
Vertical / domain-specific AI memory
Created
2025-02 third-party fix
Latest release
not applicable — not OSS fix
License
not applicable — not OSS fix
GitHub
not applicable — no GitHub repo fix
Pricing
Enterprise only vendor fix
Funding
$616M total $5.3B val Series E Extension · 2026-04 third-party fix
Freshness
2026-10-22 fix
Layer
agent-infra repo fix
Licensing
commercial vendor fix
Deployment locus
cloud vendor fix
Platform vs product
product vendor fix

Memory taxonomy

storage
file
retrieval
similarity
persistence
long-term
update
append-only
unit
episode
governance
auditable
conflict
editor-in-the-loop

When to use

Optimised for: HIPAA compliance + clinical-grade provenance + EHR integration

Anti-fit: not for non-healthcare verticals; must operate under HIPAA / regional health regulation

Pros & cons

Pros

Strongest published evidence for clinical-encounter memory accuracy; multi-EMR integrations and large hospital deployments.

Cons

Enterprise sales motion only; longitudinal cross-visit memory layered on top of single-encounter scribing rather than the architecture's primary unit.

Claims & capabilities

Deployed at major academic health systems. Inpatient + outpatient tools launched 2025. Altais physician-burnout partnership.

Technical surface

API surface
searched not found
Backend storage
searched not found
Deployment
Managed-only
Embedding model
searched not found
Multi-tenancy
US-based HIPAA-secure data centers; tenant-per-customer logical isolation; BAA with each enterprise customer
MCP
no MCP support advertised — vertical product, no MCP server / client integration documented
A2A
no A2A protocol support advertised — vertical product, no A2A integration documented
OpenTelemetry
no OpenTelemetry integration advertised — vendor logs/observability not publicly documented

Compare Abridge with…

Alternatives to Abridge → live options ranked by shared design, licence, hosting and MCP support

Similar systems

Other vertical / domain-specific ai memory in the catalog, ranked by inbound references.

  • Inworld AI T1

    Formerly an NPC character engine with named Long-Term Memory; now sells realtime voice models (TTS-2, STT-1, speech-to-speech) and OpenAI-compatible open-model inference. Character/NPC memory is no longer the headline product.

  • NVIDIA ReMEmbR T3

    Builds long-horizon memory by captioning video segments with VILA, storing captions with timestamps + 3D position coordinates in MilvusDB. At query time, LLM iterates retrieval across text, time, and position modalities. Deployed on Nova Carter robot (Jetson Orin).

  • ASAPP GenerativeAgent T1

    Treats memory as first-class architecture. Captures the digital footprint of every interaction; retrieves preference and history at engagement time. Public example: airline knowing a frequent flyer wants aisle seats with her son — preference-aware, not just history-lookup.

  • BenevolentAI T1

    Taken private: merged into Osaka Holdings (renamed BenevolentAI S.A.) and delisted from Euronext Amsterdam 2025-03-13. Target identification / drug repurposing / mechanism tracing. 85+ data sources, petabyte-scale, rebuilt every few weeks. Wet-lab results re-enter the graph and shift downstream predictions — institutional experimental memory closing a feedback loop. As of Oct 2026 benevolent.com leads with Qor, powered by BenevolentAI, a life-science intelligence service for biopharma decision makers and consultancies. Qor (qor.one) is a continuously updated decision-intelligence service built on BenevolentAI's knowledge graph and reasoning methods: it tracks evidence on an asset or indication (competitive position, rival readouts, comparable deals), source-verifies each claim and flags when an earlier conclusion stops holding. It targets biotech teams and life-science consultancies.

  • Causaly T1

    Agentic AI platform for life sciences: orchestrated scientific agents over a curated biomedical knowledge graph (plus Bio Graph and Pipeline Graph), an evidence-retrieval system and an enterprise data fabric over literature, trials and patents.

  • Character.ai T1

    Chat Memories (user-defined facts), auto-memories for c.ai+ subscribers, pinned memories, in-context retention. Latest chat models PipSqueak 3 and ShortSqueak (Sep 2026). On 2026-10-12 the company announced a voluntary Chapter 11 process for a court-supervised sale of all or substantially all assets (sale expected late Nov/early Dec 2026); the platform keeps running meanwhile and would be wound down if no viable bid emerges.

Sources (59 cited facts, 5 third-party)

Each fact links to the page it came from; the badge says who published it (how to read sources).